-
Aegis Capital Reiterates Buy Rating on Neuralstem Following 2Q13 Financial Results
Friday, August 16, 2013 - 10:49am | 241Read More...In a report published Friday, Aegis Capital analyst Raghuram Selvaraju, Ph.D. MBA reiterated a Buy rating and $4.00 price target on Neuralstem (NYSE: CUR). In the report, Aegis Capital noted, “Last week, Neuralstem reported financial results for the second quarter of 2013. The firm closed the...

